DI MARIO, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.351
EU - Europa 12.436
AS - Asia 11.422
SA - Sud America 5.434
AF - Africa 485
OC - Oceania 187
Continente sconosciuto - Info sul continente non disponibili 8
Totale 54.323
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.101
RU - Federazione Russa 6.988
BR - Brasile 4.392
SG - Singapore 2.631
HK - Hong Kong 2.258
VN - Vietnam 2.070
IE - Irlanda 1.667
CN - Cina 1.646
KR - Corea 1.274
PL - Polonia 965
IT - Italia 928
SE - Svezia 707
IN - India 506
AR - Argentina 471
DE - Germania 297
ID - Indonesia 293
GB - Regno Unito 246
EC - Ecuador 221
AU - Australia 185
CI - Costa d'Avorio 165
UA - Ucraina 118
FI - Finlandia 111
ES - Italia 108
BD - Bangladesh 102
MX - Messico 102
JO - Giordania 96
IQ - Iraq 94
JP - Giappone 94
CO - Colombia 93
CA - Canada 89
PY - Paraguay 81
ZA - Sudafrica 75
EG - Egitto 58
NL - Olanda 53
PK - Pakistan 53
FR - Francia 52
CL - Cile 44
TR - Turchia 44
VE - Venezuela 42
AT - Austria 41
CH - Svizzera 38
MA - Marocco 38
UY - Uruguay 37
KE - Kenya 36
PE - Perù 36
UZ - Uzbekistan 34
MU - Mauritius 28
SA - Arabia Saudita 26
AZ - Azerbaigian 24
TN - Tunisia 23
KZ - Kazakistan 21
DZ - Algeria 19
IR - Iran 15
TW - Taiwan 15
BG - Bulgaria 14
DO - Repubblica Dominicana 14
OM - Oman 13
AE - Emirati Arabi Uniti 12
BO - Bolivia 12
HN - Honduras 12
IL - Israele 12
LB - Libano 12
RO - Romania 12
AL - Albania 11
BJ - Benin 11
MY - Malesia 11
JM - Giamaica 10
RS - Serbia 10
GE - Georgia 9
LT - Lituania 9
NP - Nepal 9
PH - Filippine 9
BH - Bahrain 8
CZ - Repubblica Ceca 8
KW - Kuwait 8
SN - Senegal 8
BE - Belgio 7
GT - Guatemala 7
PT - Portogallo 7
KG - Kirghizistan 6
PS - Palestinian Territory 6
XK - ???statistics.table.value.countryCode.XK??? 6
GY - Guiana 5
MD - Moldavia 5
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
ET - Etiopia 4
GR - Grecia 4
LV - Lettonia 4
PA - Panama 4
AO - Angola 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
CG - Congo 3
GA - Gabon 3
HR - Croazia 3
MT - Malta 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
BW - Botswana 2
Totale 54.287
Salva come PNG Salva come JPEG
Città #
Santa Clara 5.017
Fairfield 3.231
Ashburn 2.185
Hong Kong 1.827
Singapore 1.760
Dublin 1.657
Woodbridge 1.513
Seattle 1.415
Seoul 1.259
Houston 1.227
Cambridge 1.112
Wilmington 963
Warsaw 955
Ho Chi Minh City 779
Lawrence 714
Medford 539
Princeton 505
Altamura 489
Moscow 484
Beijing 421
Hanoi 380
Ann Arbor 378
Mumbai 355
São Paulo 343
Hefei 338
Los Angeles 329
Buffalo 301
Chandler 264
Clifton 235
San Diego 222
Melbourne 169
Abidjan 165
Rio de Janeiro 159
Dallas 154
New York 154
Munich 142
The Dalles 140
Redondo Beach 117
Falls Church 115
Jakarta 108
Dong Ket 106
Florence 99
Boardman 89
Shanghai 88
Brasília 85
Haiphong 84
Norwalk 84
Da Nang 78
Barcelona 76
Curitiba 75
Quito 73
Boston 72
London 66
Porto Alegre 66
Tokyo 66
Kent 65
Belo Horizonte 64
Biên Hòa 64
Hillsboro 64
Guayaquil 62
Campinas 52
Buenos Aires 51
Hải Dương 49
Chicago 48
Baghdad 47
Guarulhos 47
Toronto 46
Redwood City 45
Thái Bình 45
Yubileyny 45
Guangzhou 44
Helsinki 44
Salvador 43
Goiânia 42
Frankfurt am Main 39
Andover 38
Ninh Bình 37
San Jose 37
Redmond 36
Montevideo 35
Turku 33
Ribeirão Preto 32
Manaus 31
Milan 30
Nairobi 30
Sumaré 30
Santo André 29
Thái Nguyên 29
Elk Grove Village 28
Johannesburg 28
Tashkent 28
Asunción 27
Fortaleza 27
Bogotá 26
Brooklyn 26
Sorocaba 26
Hortolândia 25
Bengaluru 24
Chennai 24
Lima 23
Totale 35.572
Salva come PNG Salva come JPEG
Nome #
Recanalisation of coronary chronic total occlusions 420
Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy 257
Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon 253
Perioperative myocardial infarction in elderly patients with hip fracture. Is there a role for early coronary angiography? 232
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 227
Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis 206
Second Generation: Better Also for Covered Stents? 196
Left ventricular outflow tract shape after aortic valve replacement with St. Jude Trifecta prosthesis 191
The DESolve novolimus bioresorbable Scaffold: From bench to bedside 190
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: A European perspective 186
2014 ESC guidelines on the diagnosis and treatment of aortic diseases 183
Theory and practical based approach to chronic total occlusions 177
Lo shock cardiogeno è una malattia rara che necessita di una rete dedicata 170
A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis 164
Percutaneous Trans-septal Mitral Valve-in-Ring Implantation Using a Transcatheter Balloon-Expandable Transcatheter Heart Valve With Elective Intra-Procedural Artero-Venous ECMO in a Patient With Severely Reduced Left Ventricular Ejection Fraction 164
Risk stratification using the CHA2DS2-VASc score in Takotsubo syndrome: Data from the Takotsubo Italian network 163
A Brief History of Coronary Artery Stents 162
P3527Different hemodynamic behavior of remodeling pattern one-year after aortic valve replacement in males and females 162
Calcium: A predictor of interventional treatment failure across all fields of cardiovascular medicine 162
The role for adjunctive image in pre-procedural assessment and peri-procedural management in chronic total occlusion recanalisation 162
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study 161
Hemodynamic monitoring by pulse contour analysis during trans-catheter aortic valve replacement: A fast and easy method to optimize procedure results 159
64-multislice computed tomography in consecutive patients with suspected or proven coronary artery disease: Initial single center experience 159
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry 159
Prognostic relevance of GRACE risk score in Takotsubo syndrome 159
Results of comprehensive cardiovascular diagnostic work-up in HIV positive patients 159
Contemporary approach to heavily calcified coronary lesions 158
Severe Compression of a Left Main Coronary Stent Implanted Using a Chimney Technique 156
Absorb vs. DESolve: An optical coherence tomography comparison of acute mechanical performances 155
2013 ESC guidelines on the management of stable coronary artery disease 154
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: Insights from the GHOST-EU registry 153
MitraClip Implantation to Treat Early Recurrence of Mitral Regurgitation After Percutaneous Direct Annuloplasty With Cardioband 152
Epigallocatechin-3-gallate tolerability and impact on survival in a cohort of patients with transthyretin-related cardiac amyloidosis. A single-center retrospective study 151
Unexpected delayed complete atrioventricular block after Cardioband implantation 151
How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study 151
Red flags for the diagnosis of cardiac amyloidosis: Simple suggestions to raise suspicion and achieve earlier diagnosis 150
Blood lactate predicts survival after percutaneous implantation of extracorporeal life support for refractory cardiac arrest or cardiogenic shock complicating acute coronary syndrome: insights from the CareGem registry 150
A simple step-by-step approach for proficient utilization of the EchoNavigator technology for left atrial appendage occlusion 150
Intravascular imaging to guide lithotripsy in concentric and eccentric calcific coronary lesions 150
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany 150
Quality control in treating patients with patent foramen ovale: 7-year-experience of the Heart and Brain team of the Careggi University Hospital 149
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents A Propensity-Matched Comparison of the GHOST-EU and XIENCE v USA Registries 147
Patent foramen ovale closure: how to choose the right device for the right patient 147
Coronary collaterals, the natural grafts of CTO lesions - good enough to keep most myocardium alive, unable to prevent ischaemia 147
Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not 146
A new dedicated stent and delivery system for the treatment of bifurcation lesions: Preliminary experience 146
Conquering CTO revascularisation: The summit is near with 90% of the ascent behind us 145
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study) 145
Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry 145
Perioperative myocardial infarction in patients with hip fracture: Is there a role for early coronary angiography? 145
Deep sedation vs femoral block anesthesia: beat-by-beat hemodynamic impact on TAVI procedure 145
Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience? 144
ECG abnormalities, atrial fibrillation and AV blocks in ATTR VS AL amyloidosis: an electrophysiological natural history 144
Poor right ventricular function is associated with impaired exercise capacity and ventilatory efficiency in transthyretin cardiac amyloid patients 144
Bioabsorbable vascular scaffold overexpansion: Insights from in vitro post-expansion experiments 143
Lithoplasty-assisted transfemoral aortic valve implantation 142
Serial changes in CPET parameters in untreated patients with transthyretin cardiac amyloidosis 141
A cross-sectional imaging study to identify organs at risk of thermal injury during renal artery sympathetic denervation 141
Why can flu be so deadly? An unusual case of cardiogenic shock 141
Bioresorbable vascular scaffold radial expansion and conformation compared to a metallic platform: Insights from in vitro expansion in a coronary artery lesion model 141
Biodegradable vascular scaffold: is optimal expansion the key to minimising flow disturbances and risk of adverse events? 140
Improving the net clinical benefit of dual/triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome: discovery and validation of prognostic factors for a tailored therapy 140
Aortic Stenosis and Cardiac Amyloidosis: PARTNERs in Crime? 138
Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis 138
New Advances in the Treatment of Severe Coronary Artery Calcifications 138
2-Year clinical follow-up from the randomized comparison of biolimus-eluting stents with biodegradable polymer and sirolimus-eluting stents with durable polymer in routine clinical practice 138
Baseline ECG features and arrhythmic profile in transthyretin versus light chain cardiac amyloidosis 138
Advancements in transcatheter aortic valve implantation: A focused update 138
The V-LAP System for Remote Left Atrial Pressure Monitoring of Patients With Heart Failure: Remote Left Atrial Pressure Monitoring 138
A feasibility and safety study of intracoronary hemodilution during primary coronary angioplasty in order to reduce reperfusion injury in myocardial infarction 137
The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes 137
The year in cardiology 2016: Coronary interventions 137
TAVI: New trials and registries offer further welcome evidence - U.S. CoreValve, CHOICE, and GARY 137
Intravascular lithotripsy for calcific coronary and peripheral artery stenoses 135
Biomarkers and Prediction of Prognosis in Transthyretin-Related Cardiac Amyloidosis: Direct Comparison of Two Staging Systems 135
Percutaneous Watchman FLX implantation in a patient with previous mitral valve surgery and large-sized left atrial appendage 135
Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up 135
Impact of stent strut design in metallic stents and biodegradable scaffolds 134
Perioperative myocardial infarction in patients with hip fracture: Is there a role for early coronary angiography? 134
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry 134
Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry 133
Unlike for PCI, for TAVR smaller is better 132
Cardiac amyloidosis in patient undergoing TAVR, why we need to think about it 132
Balancing idealism with realism to safeguard the welfare of patients: The importance of Heart Team led decision-making in patients with complex coronary artery disease 132
17-Beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease 132
Myocardial infarction with nonobstructed coronary arteries following accidental nitrogen inhalation: Diagnosis by cardiac magnetic resonance and coronary computed tomography 131
Use of thrombectomy devices in primary percutaneous coronary intervention: A systematic review and meta-analysis 131
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 131
"Does gender equality also apply to chronic total occlusion management?" 130
ABSORB biodegradable stents versus second-generation metal stents: A comparison study of 100 complex lesions treated under OCT guidance 130
Left ventricular mass regression after aortic valve replacement: Sex differences or effect of different methods of indexation? 130
The IMPact on Revascularization Outcomes of intraVascular ultrasound-guided treatment of complex lesions and Economic impact (IMPROVE) trial: Study design and rationale 130
Optical coherence tomography guidance during bioresorbable vascular scaffold implantation 129
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 129
P3529Left ventricular mass regression after aortic valve replacement: sex differences or effect of different methods of indexation? 129
A multicentre evaluation of the safety of intracoronary optical coherence tomography 129
Esophageal visualization changes atrial fibrillation ablation strategy: from encircling to segmental approach 129
Peripheral intravascular lithotripsy for transcatheter aortic valve implantation: a multicentre observational study 128
A coronary "tunnel": Optical coherence tomography assessment after rotational atherectomy 128
Appropriateness of percutaneous revascularization of coronary chronic total occlusions: An overview 128
Totale 15.341
Salva come PNG Salva come JPEG
Categoria #
all - tutte 174.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.359
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.988 0 0 0 0 0 1.010 140 224 601 357 402 254
2021/20223.054 45 148 260 98 89 297 72 243 299 144 255 1.104
2022/20234.946 841 1.393 207 118 67 973 766 125 243 60 100 53
2023/20242.270 39 160 554 178 109 331 94 351 60 205 124 65
2024/202517.349 846 2.211 1.365 2.766 4.515 1.742 409 581 1.327 503 481 603
2025/202615.655 1.764 3.336 2.602 5.660 2.234 59 0 0 0 0 0 0
Totale 54.965